fbpx
Home / Industry / Health Care / Valeant’s woes could prompt sale of B&L

Valeant’s woes could prompt sale of B&L

Part of Bausch & Lomb Inc.—or the entire business—soon could be on the block again. After hedge fund manager William Ackman’s declaration two weeks ago that divesting a portion of the eye care company could help solve problems faced by Bausch & Lomb parent Valeant Pharmaceuticals International Inc., a sale of some or all of the ...
x

Check Also

Jeff Pier

Child Care Council’s new leader sets eyes on growth, expanding initiatives (access required)

Part of Bausch & Lomb Inc.—or the entire business—soon could be on the block again. After hedge fund manager William ...

Aerial Stills 2014

Local colleges cautiously optimistic (access required)

Part of Bausch & Lomb Inc.—or the entire business—soon could be on the block again. After hedge fund manager William ...

ny-state-attorney-general-logo

AG extends moratorium on debt collection by her office (access required)

Part of Bausch & Lomb Inc.—or the entire business—soon could be on the block again. After hedge fund manager William ...